Characteristics of Pts Initiating Spiriva Respimat in Asthma
NCT03692676 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 116133
Last updated 2025-04-17
Summary
This study is a cross-sectional, non-interventional study based on existing data (NISed).
Conditions
Interventions
- DEVICE
-
Spiriva Respimat
soft-mist inhaler
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-05
- Primary Completion
- 2019-10-11
- Completion
- 2019-10-11
- FDA Device
- Yes
Countries
- Germany
Study Locations
More Related Trials
-
A Study to Assess the Efficacy of Inhaled Corticosteroid (ICS) Therapy in Moderate-Severe Bronchial Asthma
NCT00411567 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma With Steady State Pharmacokinetics
NCT01747629 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare the Effects of Two Propellants in Adults With Mild Asthma
NCT05472662 ·Status: COMPLETED ·Phase: PHASE2
-
Study In Asthma Control
NCT00273026 ·Status: TERMINATED ·Phase: PHASE4
-
The Use of Inflammatory Markers to Guide Therapy in Children With Severe Asthma
NCT00262340 ·Status: COMPLETED ·Phase: NA
-
Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557
NCT01462617 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Compare the Efficacy and Safety of Different Dosings of Olodaterol Administered With the Respimat® Inhaler in Patients With Moderate to Severe Asthma
NCT01311661 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Albuterol Spiromax® in Subjects With Asthma
NCT01698320 ·Status: COMPLETED ·Phase: PHASE3
-
Study In Airway Physiology In Children SERETIDE DISKUS ® Inhlaer and FLIXOTIDE® Inhaler Are Trademarks of GSK Group of Companies.
NCT00169546 ·Status: COMPLETED ·Phase: PHASE4
-
Sphingosine-1-phosphate in Asthma
NCT04134351 ·Status: UNKNOWN ·Phase: NA
-
Launching an Asthma Initiative Designed to Improve Asthma Management and Outcomes
NCT02140671 ·Status: UNKNOWN
-
Randomized, Placebo-Controlled, Multidose, Study Comparing Generic Budesonide/Formoterol Fumarate Dihydrate to Symbicort® in Asthmatic Participants
NCT02495168 ·Status: COMPLETED ·Phase: PHASE3
-
Real Life Effectiveness in Patients With Not Optimally Controlled Asthma
NCT01647646 ·Status: COMPLETED ·Phase: PHASE4
-
Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
NCT07301736 ·Status: RECRUITING ·Phase: PHASE2
-
DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults
NCT00252863 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Berodual® Respimat® Compared to Berodual® MDI (Metered Dose Inhaler) in Asthma Patients
NCT02182479 ·Status: COMPLETED ·Phase: PHASE3
-
A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients
NCT00331292 ·Status: TERMINATED
-
Cross-sectional Study for Identification and Description of Severe Asthma Patients
NCT02293265 ·Status: COMPLETED ·Phase: PHASE3
-
Local Phase 4 Pan-European SMART Study
NCT00463866 ·Status: COMPLETED ·Phase: PHASE4
-
Non-interventional Retrospective Multicenter Study of Patients With Bronchial Asthma During a Routine Visit to Out of Patients' Clinics
NCT01273363 ·Status: COMPLETED
-
Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma
NCT00476268 ·Status: COMPLETED ·Phase: PHASE3
-
Improving Asthma Treatment Using Inhaler Technology
NCT02977078 ·Status: UNKNOWN ·Phase: NA
-
Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease
NCT01369810 ·Status: COMPLETED
-
Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT
NCT00646321 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Study on Asthma Control
NCT01110460 ·Status: COMPLETED